Translational funding
Translational fundraising
Our funding events in Translational fundraising are shown below.
-
Heart Research - Novel and emerging technologies
Research projects with an emphasis on (1) novel and emerging technologies and (2) their application to cardiovascular disease prevention and/or treatment, which can be expected to benefit patients within a foreseeable timeframe, will be considered. Appropriate approaches include tissue and bioengineering, the development and evaluation of new diagnostic and therapeutic devices, bioimaging, nanotechnology, biomaterials, genomic and proteomic approaches, computational biology and bioinformatics. NET Grants are not appropriate for funding clinical trials.
-
Heart Research - Translational Research grants
Translational research bridges the gap between scientific research and patient care, bringing about clinical benefits in the most efficient way. This may advance current practice or enable innovative discoveries to be efficiently transferred into practical tools to prevent, diagnose and treat human disease.
Translational research is a dynamic and evolving process to continually improve healthcare and should not stop once the technology is at the patient's bedside. It can be thought of as taking a scientific breakthrough from ‘laboratory bench to hospital bedside and back to bench’ to be further improved. For example, it may help to explain why some treatments stop working or why side-effects may occur.
These grants show our commitment to supporting innovative 'bench-to-bedside' research which can improve the health and treatment of patients with cardiovascular disease.
Maximum award: £150,000
Closing date: 1pm, 1 February every year, applications accepted from the beginning of January. -
MRC - Translational Stem Cell Research funding
The Translational Stem Cell Research Committee (TSCRC) has been established to fund investigator-led research proposals that have clear translational goals, and will consider applications from across the UK. The funding mechanism will also provide a platform for partnership funding which will be considered on a case-by-case basis.
-
Wellcome Trust and Department of Health - Health Innovation Challenge Fund
The Health Innovation Challenge Fund (HICF) is a parallel funding partnership between the Wellcome Trust and the Department of Health. The funders are collaborating to stimulate the creation of innovative healthcare products, technologies and interventions, and facilitate their development for the benefit of patients in the NHS and beyond. The HICF will have a succession of thematic calls for proposals, each selected to focus on unmet needs in healthcare relevant to the NHS, and will support innovative developments that are within three to five years of launch or adoption.
-
Wellcome Trust - R&D for Affordable Healthcare in India
The objective of this initiative is to fund translational research projects that will deliver safe and effective healthcare products for India - and potentially other markets - at affordable costs. A key feature of the scheme is that it encourages innovations that bring together researchers from both the public and private sectors to extend access to care to the greatest numbers of beneficiaries, without compromising on quality.
-
Wellcome Trust - Strategic Translation Awards
Invited applications for applied R&D projects that are close to existing Wellcome Trust interests. For example, these may build on Trust initiatives in basic science, such as genome-wide association studies, healthcare in low- and middle-income countries, or in areas like malaria, typhoid or TB.
-
Wellcome Trust - Translational Awards
For applied R&D projects that address an unmet need in healthcare. They are open to academic researchers and companies, and can address almost any area of healthcare. Projects covering any aspect of technology development from a range of disciplines - including physical, computational and life sciences - will be considered. Projects must address an unmet need in healthcare or in applied medical research, offer a potential new solution, and have a realistic expectation that the innovation will be developed further by the market.